Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


Emergency GCC-EU meeting to discuss Iranian aggression
Omani navy rescues cargo ship crew after missile strike
UN 'deeply disturbed' by strike on Iran school that killed 160 children
Saudi confirms attempted attack on oil refinery, no damage
At least four killed in Israeli strike on building in Lebanon's Baalbek